Chindex International Inc (CHDX.OQ)

CHDX.OQ on NASDAQ Stock Exchange Global Select Market

23.86USD
28 Aug 2014
Price Change (% chg)

$-0.06 (-0.25%)
Prev Close
$23.92
Open
$23.88
Day's High
$23.92
Day's Low
$23.86
Volume
3,618
Avg. Vol
--
52-wk High
--
52-wk Low
--

CHDX.OQ

Chart for CHDX.OQ

About

Chindex International Inc. is a healthcare company. The Company is engaged in providing health care services in China through the operations of United Family Healthcare and providing medical capital equipment and products through Chindex Medical Ltd. United Family Healthcare is a network of private primary care hospitals and... (more)
No analyst recommendations are available for CHDX.OQ.

Overall

Beta: 1.37
Market Cap (Mil.): $436.86
Shares Outstanding (Mil.): 18.26
Dividend: --
Yield (%): --

Financials

  CHDX.OQ Industry Sector
P/E (TTM): -- 31.10 33.40
EPS (TTM): -0.59 -- --
ROI: -5.10 8.53 17.27
ROE: -6.41 13.15 18.02
Search Stocks

UPDATE 1-Fosun Pharma, TPG agree to buy Chindex in sweetened $461 mln deal

SHANGHAI, April 21 - Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd and private equity firm TPG Capital agreed to buy China-focused Chindex International Inc in a beefed-up $461 million deal after trumping a rival bid.

21 Apr 2014

China's Fosun Pharma raises offer for hospital chain Chindex Int'l to $223.6 mln

SHANGHAI, April 21 - Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed Chindex International Inc by 15 percent to $223.6 million after a bidding war for the China-focused hospital chain.

21 Apr 2014

BRIEF-Fosun Pharma raises buyout offer for Chindex Int'l to $24/shr

April 21 - Shanghai Fosun Pharmaceutical Group Co Ltd

21 Apr 2014

Chindex International gets higher buyout offer from unnamed bidder

April 14 - China-focused hospital operator Chindex International Inc received a buyout offer of $23 per share, higher than the $19.50 offered by Shanghai Fosun Pharmaceutical Group and private equity firm TPG in February.

14 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks